Skip to content

A multicenter study of metabolic syndrome and its risk factors in patients with Vitiligo in Xinjiang

A multicenter study of metabolic syndrome and its risk factors in patients with vitiligo in Xinjiang

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400087767
Enrollment
Unknown
Registered
2024-08-05
Start date
2024-08-10
Completion date
Unknown
Last updated
2024-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

vitiligo

Interventions

Vitiligo
Vitiligo with metabolic syndrome:none

Sponsors

Dermatology and venereal Medicine Diagnosis and Treatment Center, People's Hospital of Xinjiang Uygur Autonomous Region
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Dermatologist definitively diagnosed patients with vitiligo (2) Age 6-80 years old (including the upper and lower limits) [on the date of signing the ICF]; (3) Meet the diagnostic criteria of metabolic syndrome: BMI of 28kg/m2 or more; (4) 1) Female waist > 80cm, or waist-to-hip ratio >0.8, male waist >90cm, or waist-to-hip ratio >0.9 2) Triglyceride > 4.8mmol/L 3) HDL cholesterol 130/85mmHg 5) Fasting blood glucose 6.1-6.9 nmol/L 6) 2h OGTT (75g glucose) 7.8-11.1nmol/L Obesity is a necessary indicator in the above criteria, and 3 of the remaining 5 items can be diagnosed. (5) In the case of women of childbearing age, it should not be during pregnancy or breastfeeding; (6) The subject must be able to communicate well with the investigator, comply with the requirements of the study, and sign written informed consent. (7) Subjects must be willing and able to complete study procedures and follow-up examinations.

Exclusion criteria

Exclusion criteria: (1) There are mental disorders or visual and hearing disorders that hinder the normal conduct of the questionnaire survey; (2) Those who refuse to participate in the informed consent process or are unable to cooperate with the completion of routine blood tests. (3) Unable to understand or cooperate with the interviewees in this project.

Design outcomes

Primary

MeasureTime frame
Vitiligo Disease Activity, VIDA;

Secondary

MeasureTime frame
Dermatology Life Quality Index, DLQI;

Countries

China

Contacts

Public ContactKang Xiaojing

People's Hospital of Xinjiang Uygur Autonomous Region

drkangxj666@163.com+86 139 9992 7999

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026